
An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK). CAMBRIDGE, 02-Jun-2016 — /EuropaWire/ — The technique involves … Read the full press release